 | • レポートコード：QYR2104Z2961 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ヒト血漿由来治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体濃縮物、その他）、用途別市場規模（病院、クリニック、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒト血漿由来治療の市場動向 ・企業の競争状況、市場シェア ・ヒト血漿由来治療の種類別市場規模（アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体濃縮物、その他） ・ヒト血漿由来治療の用途別市場規模（病院、クリニック、研究センター） ・ヒト血漿由来治療の北米市場規模2016-2027（アメリカ、カナダ） ・ヒト血漿由来治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト血漿由来治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト血漿由来治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト血漿由来治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alkahest、Baxter、CSL Behring、Entegrion, Inc.、Gammagard、Grifols、Kedrion、Octapharma、Prometic Life Sciences、Sanquin、Takeda） ・結論 |
Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market
The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Plasma-Derived Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Plasma-Derived Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Plasma-Derived Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Plasma-Derived Therapeutics market.
Global Human Plasma-Derived Therapeutics Scope and Market Size
Human Plasma-Derived Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Plasma-Derived Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Albumin
Immunoglobulin
Clotting Factor
Prothrombin Complex
Others
Segment by Application
Hospital
Clinic
Research Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Alkahest
Baxter
CSL Behring
Entegrion, Inc.
Gammagard
Grifols
Kedrion
Octapharma
Prometic Life Sciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Plasma-Derived Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Prothrombin Complex
1.2.6 Others
1.3 Market by Application
1.3.1 Global Human Plasma-Derived Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Plasma-Derived Therapeutics Market Perspective (2016-2027)
2.2 Human Plasma-Derived Therapeutics Growth Trends by Regions
2.2.1 Human Plasma-Derived Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Plasma-Derived Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Human Plasma-Derived Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Human Plasma-Derived Therapeutics Industry Dynamic
2.3.1 Human Plasma-Derived Therapeutics Market Trends
2.3.2 Human Plasma-Derived Therapeutics Market Drivers
2.3.3 Human Plasma-Derived Therapeutics Market Challenges
2.3.4 Human Plasma-Derived Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Plasma-Derived Therapeutics Players by Revenue
3.1.1 Global Top Human Plasma-Derived Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Human Plasma-Derived Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Human Plasma-Derived Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Plasma-Derived Therapeutics Revenue
3.4 Global Human Plasma-Derived Therapeutics Market Concentration Ratio
3.4.1 Global Human Plasma-Derived Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Plasma-Derived Therapeutics Revenue in 2020
3.5 Human Plasma-Derived Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Plasma-Derived Therapeutics Product Solution and Service
3.7 Date of Enter into Human Plasma-Derived Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Plasma-Derived Therapeutics Breakdown Data by Type
4.1 Global Human Plasma-Derived Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Human Plasma-Derived Therapeutics Forecasted Market Size by Type (2022-2027)
5 Human Plasma-Derived Therapeutics Breakdown Data by Application
5.1 Global Human Plasma-Derived Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Human Plasma-Derived Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human Plasma-Derived Therapeutics Market Size (2016-2027)
6.2 North America Human Plasma-Derived Therapeutics Market Size by Type
6.2.1 North America Human Plasma-Derived Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Human Plasma-Derived Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Human Plasma-Derived Therapeutics Market Size by Type (2016-2027)
6.3 North America Human Plasma-Derived Therapeutics Market Size by Application
6.3.1 North America Human Plasma-Derived Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Human Plasma-Derived Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Human Plasma-Derived Therapeutics Market Size by Application (2016-2027)
6.4 North America Human Plasma-Derived Therapeutics Market Size by Country
6.4.1 North America Human Plasma-Derived Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Human Plasma-Derived Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Human Plasma-Derived Therapeutics Market Size (2016-2027)
7.2 Europe Human Plasma-Derived Therapeutics Market Size by Type
7.2.1 Europe Human Plasma-Derived Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Human Plasma-Derived Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Human Plasma-Derived Therapeutics Market Size by Type (2016-2027)
7.3 Europe Human Plasma-Derived Therapeutics Market Size by Application
7.3.1 Europe Human Plasma-Derived Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Human Plasma-Derived Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Human Plasma-Derived Therapeutics Market Size by Application (2016-2027)
7.4 Europe Human Plasma-Derived Therapeutics Market Size by Country
7.4.1 Europe Human Plasma-Derived Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Human Plasma-Derived Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human Plasma-Derived Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Type
8.2.1 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Application
8.3.1 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Region
8.4.1 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Plasma-Derived Therapeutics Market Size (2016-2027)
9.2 Latin America Human Plasma-Derived Therapeutics Market Size by Type
9.2.1 Latin America Human Plasma-Derived Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Human Plasma-Derived Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Human Plasma-Derived Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Human Plasma-Derived Therapeutics Market Size by Application
9.3.1 Latin America Human Plasma-Derived Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Human Plasma-Derived Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Human Plasma-Derived Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Human Plasma-Derived Therapeutics Market Size by Country
9.4.1 Latin America Human Plasma-Derived Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Human Plasma-Derived Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Plasma-Derived Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type
10.2.1 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application
10.3.1 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Country
10.4.1 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alkahest
11.1.1 Alkahest Company Details
11.1.2 Alkahest Business Overview
11.1.3 Alkahest Human Plasma-Derived Therapeutics Introduction
11.1.4 Alkahest Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.1.5 Alkahest Recent Development
11.2 Baxter
11.2.1 Baxter Company Details
11.2.2 Baxter Business Overview
11.2.3 Baxter Human Plasma-Derived Therapeutics Introduction
11.2.4 Baxter Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.2.5 Baxter Recent Development
11.3 CSL Behring
11.3.1 CSL Behring Company Details
11.3.2 CSL Behring Business Overview
11.3.3 CSL Behring Human Plasma-Derived Therapeutics Introduction
11.3.4 CSL Behring Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.3.5 CSL Behring Recent Development
11.4 Entegrion, Inc.
11.4.1 Entegrion, Inc. Company Details
11.4.2 Entegrion, Inc. Business Overview
11.4.3 Entegrion, Inc. Human Plasma-Derived Therapeutics Introduction
11.4.4 Entegrion, Inc. Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.4.5 Entegrion, Inc. Recent Development
11.5 Gammagard
11.5.1 Gammagard Company Details
11.5.2 Gammagard Business Overview
11.5.3 Gammagard Human Plasma-Derived Therapeutics Introduction
11.5.4 Gammagard Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.5.5 Gammagard Recent Development
11.6 Grifols
11.6.1 Grifols Company Details
11.6.2 Grifols Business Overview
11.6.3 Grifols Human Plasma-Derived Therapeutics Introduction
11.6.4 Grifols Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.6.5 Grifols Recent Development
11.7 Kedrion
11.7.1 Kedrion Company Details
11.7.2 Kedrion Business Overview
11.7.3 Kedrion Human Plasma-Derived Therapeutics Introduction
11.7.4 Kedrion Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.7.5 Kedrion Recent Development
11.8 Octapharma
11.8.1 Octapharma Company Details
11.8.2 Octapharma Business Overview
11.8.3 Octapharma Human Plasma-Derived Therapeutics Introduction
11.8.4 Octapharma Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.8.5 Octapharma Recent Development
11.9 Prometic Life Sciences
11.9.1 Prometic Life Sciences Company Details
11.9.2 Prometic Life Sciences Business Overview
11.9.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Introduction
11.9.4 Prometic Life Sciences Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.9.5 Prometic Life Sciences Recent Development
11.10 Sanquin
11.10.1 Sanquin Company Details
11.10.2 Sanquin Business Overview
11.10.3 Sanquin Human Plasma-Derived Therapeutics Introduction
11.10.4 Sanquin Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.10.5 Sanquin Recent Development
11.11 Takeda
11.11.1 Takeda Company Details
11.11.2 Takeda Business Overview
11.11.3 Takeda Human Plasma-Derived Therapeutics Introduction
11.11.4 Takeda Revenue in Human Plasma-Derived Therapeutics Business (2016-2021)
11.11.5 Takeda Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Human Plasma-Derived Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Albumin
Table 3. Key Players of Immunoglobulin
Table 4. Key Players of Clotting Factor
Table 5. Key Players of Prothrombin Complex
Table 6. Key Players of Others
Table 7. Global Human Plasma-Derived Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Human Plasma-Derived Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Human Plasma-Derived Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Human Plasma-Derived Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Human Plasma-Derived Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Human Plasma-Derived Therapeutics Market Share by Regions (2022-2027)
Table 13. Human Plasma-Derived Therapeutics Market Trends
Table 14. Human Plasma-Derived Therapeutics Market Drivers
Table 15. Human Plasma-Derived Therapeutics Market Challenges
Table 16. Human Plasma-Derived Therapeutics Market Restraints
Table 17. Global Human Plasma-Derived Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Human Plasma-Derived Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Human Plasma-Derived Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Plasma-Derived Therapeutics as of 2020)
Table 20. Ranking of Global Top Human Plasma-Derived Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Human Plasma-Derived Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Human Plasma-Derived Therapeutics Product Solution and Service
Table 24. Date of Enter into Human Plasma-Derived Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Plasma-Derived Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Human Plasma-Derived Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Human Plasma-Derived Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Human Plasma-Derived Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Human Plasma-Derived Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Human Plasma-Derived Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Human Plasma-Derived Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Human Plasma-Derived Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Human Plasma-Derived Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Human Plasma-Derived Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Human Plasma-Derived Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Human Plasma-Derived Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Human Plasma-Derived Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Human Plasma-Derived Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Human Plasma-Derived Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Human Plasma-Derived Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Human Plasma-Derived Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Human Plasma-Derived Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Human Plasma-Derived Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Human Plasma-Derived Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Human Plasma-Derived Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Human Plasma-Derived Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Human Plasma-Derived Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Human Plasma-Derived Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Human Plasma-Derived Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Human Plasma-Derived Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Human Plasma-Derived Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Alkahest Company Details
Table 65. Alkahest Business Overview
Table 66. Alkahest Human Plasma-Derived Therapeutics Product
Table 67. Alkahest Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Alkahest Recent Development
Table 69. Baxter Company Details
Table 70. Baxter Business Overview
Table 71. Baxter Human Plasma-Derived Therapeutics Product
Table 72. Baxter Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Baxter Recent Development
Table 74. CSL Behring Company Details
Table 75. CSL Behring Business Overview
Table 76. CSL Behring Human Plasma-Derived Therapeutics Product
Table 77. CSL Behring Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 78. CSL Behring Recent Development
Table 79. Entegrion, Inc. Company Details
Table 80. Entegrion, Inc. Business Overview
Table 81. Entegrion, Inc. Human Plasma-Derived Therapeutics Product
Table 82. Entegrion, Inc. Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Entegrion, Inc. Recent Development
Table 84. Gammagard Company Details
Table 85. Gammagard Business Overview
Table 86. Gammagard Human Plasma-Derived Therapeutics Product
Table 87. Gammagard Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Gammagard Recent Development
Table 89. Grifols Company Details
Table 90. Grifols Business Overview
Table 91. Grifols Human Plasma-Derived Therapeutics Product
Table 92. Grifols Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Grifols Recent Development
Table 94. Kedrion Company Details
Table 95. Kedrion Business Overview
Table 96. Kedrion Human Plasma-Derived Therapeutics Product
Table 97. Kedrion Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Kedrion Recent Development
Table 99. Octapharma Company Details
Table 100. Octapharma Business Overview
Table 101. Octapharma Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Octapharma Recent Development
Table 103. Prometic Life Sciences Company Details
Table 104. Prometic Life Sciences Business Overview
Table 105. Prometic Life Sciences Human Plasma-Derived Therapeutics Product
Table 106. Prometic Life Sciences Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Prometic Life Sciences Recent Development
Table 108. Sanquin Company Details
Table 109. Sanquin Business Overview
Table 110. Sanquin Human Plasma-Derived Therapeutics Product
Table 111. Sanquin Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Sanquin Recent Development
Table 113. Takeda Company Details
Table 114. Takeda Business Overview
Table 115. Takeda Human Plasma-Derived Therapeutics Product
Table 116. Takeda Revenue in Human Plasma-Derived Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Takeda Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Plasma-Derived Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Albumin Features
Figure 3. Immunoglobulin Features
Figure 4. Clotting Factor Features
Figure 5. Prothrombin Complex Features
Figure 6. Others Features
Figure 7. Global Human Plasma-Derived Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Research Center Case Studies
Figure 11. Human Plasma-Derived Therapeutics Report Years Considered
Figure 12. Global Human Plasma-Derived Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Human Plasma-Derived Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Human Plasma-Derived Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Human Plasma-Derived Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Human Plasma-Derived Therapeutics Market Share by Players in 2020
Figure 17. Global Top Human Plasma-Derived Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Plasma-Derived Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Human Plasma-Derived Therapeutics Revenue in 2020
Figure 19. Global Human Plasma-Derived Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Human Plasma-Derived Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Human Plasma-Derived Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Human Plasma-Derived Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Human Plasma-Derived Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Human Plasma-Derived Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Human Plasma-Derived Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Human Plasma-Derived Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Human Plasma-Derived Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Human Plasma-Derived Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Human Plasma-Derived Therapeutics Market Share by Region (2016-2027)
Figure 41. China Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Human Plasma-Derived Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Human Plasma-Derived Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Human Plasma-Derived Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Human Plasma-Derived Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Human Plasma-Derived Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Human Plasma-Derived Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Human Plasma-Derived Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Alkahest Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 61. Baxter Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 62. CSL Behring Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 63. Entegrion, Inc. Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 64. Gammagard Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 65. Grifols Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 66. Kedrion Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 67. Octapharma Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 68. Prometic Life Sciences Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 69. Sanquin Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 70. Takeda Revenue Growth Rate in Human Plasma-Derived Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界のプラズマ治療薬市場規模・現状・予測（2021年-2027年） Plasma, pale yellow in color, is the component of the blood. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI. M…- 世界の血漿由来医薬品市場 2021：企業別、地域別、種類・用途別 The Plasma Derived Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の血漿タンパク質治療薬市場規模・現状・予測（2021年-2027年） Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product…
- 世界のヒトマイクロバイオーム治療市場規模・現状・予測（2021年-2027年） Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…
- 世界のヒトパピローマウイルス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Papillomaviru Therapeutics Market The global Human Papillomaviru Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…